{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:14:26Z","timestamp":1765728866278,"version":"3.32.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.micpath.2023.106217","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:49:59Z","timestamp":1687913399000},"page":"106217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of integrase inhibitor-related drug resistance mutations in newly diagnosed ART-na\u00efve HIV patients"],"prefix":"10.1016","volume":"181","author":[{"given":"Nan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-0209","authenticated-orcid":false,"given":"Xuping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2023.106217_bib1","series-title":"Major Infectious Diseases","article-title":"Global mortality and morbidity of HIV\/AIDS","author":"Danforth","year":"2017"},{"key":"10.1016\/j.micpath.2023.106217_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","article-title":"Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis","volume":"23","author":"Attia","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2023.106217_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/157016209788347976","article-title":"Emerging of HIV drug resistance: epidemiology, diagnosis, treatment and prevention","volume":"7","author":"Kiertiburanakul","year":"2009","journal-title":"CHR"},{"key":"10.1016\/j.micpath.2023.106217_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2217\/fvl-2019-0077","article-title":"Update on HIV integrase inhibitors for the treatment of HIV-1 infection","volume":"14","author":"Max","year":"2019","journal-title":"Future Virol."},{"key":"10.1016\/j.micpath.2023.106217_bib5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/QAD.0000000000001894","article-title":"Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine\/tenofovir alafenamide","volume":"32","author":"Sax","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2023.106217_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/QAD.0000000000001494","article-title":"Emergent drug resistance with integrase strand transfer inhibitor-based regimens","volume":"31","author":"Lepik","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2023.106217_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000001649","article-title":"Prevalence of primary drug resistance against HIV-1 integrase inhibitors in Canada","volume":"78","author":"Ji","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.micpath.2023.106217_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2018.8431","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel","volume":"320","author":"Saag","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2023.106217_bib9","unstructured":"Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, (n.d.) 585."},{"key":"10.1016\/j.micpath.2023.106217_bib10","first-page":"400","article-title":"Drug resistance to HIV-1 integrase inhibitors among treatment-naive patients in Jiangsu, China","volume":"34","author":"Yin","year":"2021","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.micpath.2023.106217_bib11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s15010-021-01668-9","article-title":"Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018\u20132020)","volume":"49","author":"Yang","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.micpath.2023.106217_bib12","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/QAD.0000000000002282","article-title":"Lack of HIV-1 integrase inhibitor resistance among 392 antiretroviral-na\u00efve individuals in a tertiary care hospital in Beijing, China","volume":"33","author":"Liu","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2023.106217_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/srep35779","article-title":"Prevalence of integrase strand transfer inhibitors (INSTI) resistance mutations in taiwan","volume":"6","author":"Chang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2023.106217_bib14","first-page":"1106","article-title":"Chinese medical association, Chinese center for disease control and prevention, [Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2021 edition)]","volume":"60","year":"2021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.micpath.2023.106217_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/infdis\/jiu051","article-title":"VIKING-3 Study Group, Dolutegravir in antiretroviral-experienced patients with raltegravir- and\/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study","volume":"210","author":"Castagna","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2023.106217_bib16","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1038\/s41467-020-19801-x","article-title":"Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase","volume":"11","author":"Siedner","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2023.106217_bib17","doi-asserted-by":"crossref","first-page":"E1330","DOI":"10.3390\/v12111330","article-title":"Emergence of resistance to integrase strand transfer inhibitors during dolutegravir containing triple-therapy in a treatment-experienced patient with pre-existing M184V\/I mutation","volume":"12","author":"Braun","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2023.106217_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cid\/cit697","article-title":"Resistance to HIV integrase strand transfer inhibitors among clinical specimens in the United States, 2009-2012","volume":"58","author":"Hurt","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2023.106217_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jac\/dkx511","article-title":"Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen","volume":"73","author":"Charpentier","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2023.106217_bib20","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1097\/QAD.0000000000001616","article-title":"The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro","volume":"31","author":"Saladini","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2023.106217_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12879-019-3927-1","article-title":"Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2023.106217_bib22","article-title":"Phylogenetic and temporal dynamics of human immunodeficiency virus type 1 CRF01_AE and CRF07_BC among recently infected antiretroviral therapy-na\u00efve men who have sex with men in Jiangsu province, China, 2012 to 2015: a molecular epidemiology-based study","volume":"97","author":"Yang","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.micpath.2023.106217_bib23","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00705-018-3839-1","article-title":"Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017","volume":"163","author":"Xu","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.micpath.2023.106217_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00705-018-4051-z","article-title":"Genetic characterization of a novel unique recombinant form of HIV-1 originating from subtype A1 and C in Guangdong Province, China","volume":"164","author":"Deng","year":"2019","journal-title":"Arch. Virol."},{"key":"10.1016\/j.micpath.2023.106217_bib25","article-title":"HIV-1 molecular epidemiology among newly diagnosed HIV-1 individuals in Hebei, a low HIV prevalence province in China","volume":"12","author":"Lu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2023.106217_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S0950268817003016","article-title":"Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing","volume":"146","author":"Song","year":"2018","journal-title":"Epidemiol. Infect."},{"year":"2017","series-title":"Guidelines on the Public Health Response to Pretreatment HIV Drug Resistance: July 2017","author":"World Health Organization","key":"10.1016\/j.micpath.2023.106217_bib27"},{"key":"10.1016\/j.micpath.2023.106217_bib28","article-title":"Evolutionary dynamics and complicated genetic transmission network patterns of HIV-1 CRF01_AE among MSM in Shanghai, China","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2023.106217_bib29","unstructured":"PI Resistance Comments - HIV Drug Resistance Database, (n.d.). https:\/\/hivdb.stanford.edu\/dr-summary\/comments\/PI\/(accessed November 24, 2022)."},{"key":"10.1016\/j.micpath.2023.106217_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3851\/IMP1750","article-title":"Transmitted resistance to HIV integrase strand-transfer inhibitors: right on schedule","volume":"16","author":"Hurt","year":"2011","journal-title":"Antivir. Ther."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023002504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023002504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:35:14Z","timestamp":1736404514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401023002504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":30,"alternative-id":["S0882401023002504"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106217","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of integrase inhibitor-related drug resistance mutations in newly diagnosed ART-na\u00efve HIV patients","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106217"}}